Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies

Research output: Contribution to journalArticle

9 Citations (Scopus)
84 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies'. Together they form a unique fingerprint.

Medicine & Life Sciences